Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132244) titled 'A prospective real - world clinical study on the use of Reduning Injection for the prevention of sepsis in high - risk populations with respiratory system infections' on Sept. 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First People's Hospital of Lianyungang
Condition:
Respiratory infections
Intervention:
Conventional Treatment:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-11
Target Sample Size: Conventional Treatment:1603;Conventional Treatment plus Reduning Injection:1603;
Countries of Recruitment:
China
To know m...